For Research Use Only · Not For Human or Veterinary Use · Not FDA-Approved

— Research monograph

KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV)

KLOWfour-peptide blend

A four-peptide repair blend adding the KPV tripeptide to the GLOW base.

Class
Merit co-formulation: BPC-157 + GHK-Cu + TB-500 + KPV
Half-life (research)
Component-dependent (see the individual component records).
Origin
KLOW is a Merit-specific four-component co-formulation. It extends the GLOW blend with KPV, the C-terminal tripeptide (lysine-proline-valine) of alpha-melanocyte-stimulating hormone (α-MSH).
Solubility
Water-soluble; reconstitutes in bacteriostatic water.

What is KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV)?

KLOW combines four peptides recurrent in repair and immune-signaling research: BPC-157, GHK-Cu, TB-500, and KPV. KPV is the C-terminal fragment of α-MSH and is studied for anti-inflammatory signaling that appears, in some models, to act independently of the melanocortin-1 receptor.

As a co-formulation, KLOW has no separate published record; the literature belongs to each component. Merit supplies it as a single research preparation for laboratory use only.

How does KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV) work?

Component-level: BPC-157 (cytoprotection / angiogenesis), GHK-Cu (matrix remodeling), TB-500 (actin / cell migration), and KPV (NF-κB-pathway modulation in inflammation models). No combined mechanism is established for the blend.

Research applications

  • Tissue-repair and remodeling research (component-based)
  • Inflammation-pathway models (KPV)
  • Extracellular-matrix studies
  • Comparative peptide co-formulation research

Handling & reconstitution

KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV) ships as a sealed, lyophilized (freeze-dried) powder and is reconstituted with bacteriostatic water for laboratory handling. Water-soluble; reconstitutes in bacteriostatic water. Concentration equals vial mass divided by diluent volume.

See the Klow blend reconstitution protocol for a step-by-step guide and an interactive research calculator (vial size → diluent → draw volume).

Frequently asked questions

What is KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV)?

KLOW combines four peptides recurrent in repair and immune-signaling research: BPC-157, GHK-Cu, TB-500, and KPV. KPV is the C-terminal fragment of α-MSH and is studied for anti-inflammatory signaling that appears, in some models, to act independently of the melanocortin-1 receptor. Merit supplies it as a lyophilized research compound for research use only — not for human or veterinary use.

How does KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV) work?

Component-level: BPC-157 (cytoprotection / angiogenesis), GHK-Cu (matrix remodeling), TB-500 (actin / cell migration), and KPV (NF-κB-pathway modulation in inflammation models). No combined mechanism is established for the blend. Mechanistic descriptions summarize published preclinical findings and are not clinical claims.

What is the half-life of KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV)?

Component-dependent (see the individual component records). Values reflect preclinical or research-context reports, not clinical pharmacokinetics.

How is KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV) reconstituted for research?

A lyophilized vial is reconstituted with bacteriostatic water; concentration equals vial mass divided by diluent volume. See the KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV) reconstitution protocol for a step-by-step guide and a research calculator.

Is Merit KLOW Blend (BPC-157 · GHK-Cu · TB-500 · KPV) for human use?

No. It is sold strictly for research use only — not for human or veterinary use, and not for diagnostic or therapeutic use. Every lot ships with a certificate of analysis documenting ≥99% HPLC purity.

References

  1. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Dalmasso G, Charrier-Hisamuddin L, Nguyen HTT, et al.. Gastroenterology, 2008 · doi:10.1053/j.gastro.2007.11.041
  2. Stable gastric pentadecapeptide BPC 157 in the treatment of various organ lesions (review). Sikiric P, Seiwerth S, Rucman R, et al.. Current Pharmaceutical Design, 2011 · doi:10.2174/138161211796196907

For research use only. Not for human or veterinary use. Not FDA-approved. Reference information summarized from published literature — not medical or dosing advice.